SOURCE: iData Research

iData Research

July 14, 2016 13:41 ET

Genzyme, DePuy Synthes, Zimmer Biomet Products Preferred by Physicians Surveyed at AAOS 2016

Physicians Interviewed at AAOS Came From a Total of 37 Countries; Those Who Came From North and Latin America Accounted for the Two Largest Groups of Respondents at 19.4% and 28.6%, Respectively

VANCOUVER, BC--(Marketwired - July 14, 2016) - iData Research, an international medical market research firm, conducted an in-person survey at the 2016 American Academy of Orthopaedic Surgeons (AAOS) annual meeting in Orlando, Florida from March 1-5. One of the notable results showed that among physicians surveyed, the majority of respondents stated that they are more inclined to administer single-injection hyaluronic acid (HA) viscosupplementation treatments rather than the three- or five-dose cycle injection treatments. This result shows that the convenience of a single-injection procedure has aided in its market penetration.

A total of 14,509 health professionals and 10,493 exhibitors attended the meeting. The survey measured end-user attitudes and perceptions towards the markets for orthopedic biomaterials, joint reconstruction and extremities reconstruction. Responses from hundreds of orthopedic surgeons from a total of 37 countries were gathered during the AAOS conference.

"iData's Global Physician Surveys are conducted by highly trained moderators with years of experience in applying iData's rigorous methodology. This ensures that balanced responses are given and elicits keen insight from physicians, surgeons, specialists and other medical professionals," explains Dr. Kamran Zamanian, CEO of iData. "iData's Global Physician Surveys are used to garner brand awareness, product preferences, message feedback and positioning."

The Global Survey on Orthopedic Biomaterials, Joint Reconstruction and Extremities Reconstruction covers physicians from the United States, Canada, Mexico, Argentina, Brazil, Colombia, Ecuador, Haiti, Jamaica, Dominican Republic, Venezuela, France, Italy, Switzerland, United Kingdom, Bulgaria, Greece, Poland, Romania, Russia, Israel, Jordan, Lebanon, Pakistan, Saudi Arabia, Turkey, UAE, Egypt, South Africa, Australia, China, India, Japan, Philippines, Singapore, South Korea and Thailand. Some of the findings include:

  • For single-injection HA treatments, the physicians surveyed indicated that they most often used Synvisc® by manufacturer Genzyme, mainly due to its favorable clinical outcomes.
  • During total knee replacement procedures, physicians surveyed preferred implants from DePuy Synthes and Zimmer Biomet due to their product quality.

Respondents were initially asked how many patients they saw on average each week. Results show that each physician surveyed saw an average of 30 patients each week. Other questions from the Global Survey on Orthopedic Biomaterials, Joint Reconstruction and Extremities Reconstruction include:

  • For three- and five- dose injection HA treatments, what products do you use the most?
  • When performing surgical procedures, what type of bone graft do you use the most?
  • For what reason do you prefer a particular manufacturer's knee/hip replacement implants?
  • Who are your top three most trusted bone graft manufactures?
  • What do you see as the biggest disadvantage of using patient-specific implants today?
  • Based on your knowledge and experience, do you believe that stemless shoulder devices should become the standard of care for shoulder arthritis requiring replacement?
  • When implanting distal radius plates, do you have a preference for volar or dorsal plates?
  • Given the current ankle replacement technology, do you believe that replacement should become the standard of care for treatment of ankle arthritis over plates and nails?

For Further Information

To learn more about physician preferences in the orthopedic market ask for a survey published by iData Research entitled the Global Survey on Orthopedic Biomaterials, Joint Reconstruction and Extremities. The survey covers user preferences on the following markets: Orthopedic Biomaterials, Joint Reconstruction Devices and Extremities Reconstruction Devices.

iData reports and surveys provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about orthopedic preference survey data, register online or email us at info@idataresearch.net for a Global Survey on Orthopedic Biomaterials, Joint Reconstruction and Extremities brochure and synopsis.

About iData Research

iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Orthopedics, Orthopedic Trauma, Large & Small Joints, Orthopedic Soft Tissue Repair and Regeneration, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Anesthesiology, Wound Management, , Ophthalmics, Dental Operatory Equipment and more.

Contact Information